Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenomics: the implementation phase.

Wolfgang Sadee1

  • 1College of Medicine and Public Health, Ohio State University, Columbus, OH 043210-1239, USA. sadee.1@osu.edu

AAPS Pharmsci
|July 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability.

Communications biology·2025
Same author

Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics.

Molecules (Basel, Switzerland)·2023
Same author

Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability.

Research square·2023
Same author

Pharmacogenomics: Driving Personalized Medicine.

Pharmacological reviews·2023
Same author

Transcription Factors and ncRNAs Associated with <i>CYP3A</i> Expression in Human Liver and Small Intestine Assessed with Weighted Gene Co-Expression Network Analysis.

Biomedicines·2022
Same author

Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction.

Molecules (Basel, Switzerland)·2022
Same journal

Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation.

AAPS pharmSci·2005
Same journal

Evaluation of the potential use of poly(ethylene oxide) as tablet- and extrudate-forming material.

AAPS pharmSci·2005
Same journal

Acute and subchronic (28-day) oral toxicity study in rats fed with novel surfactants.

AAPS pharmSci·2005
Same journal

Permeability classification of representative fluoroquinolones by a cell culture method.

AAPS pharmSci·2005
Same journal

A photo-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications.

AAPS pharmSci·2004
Same journal

Pharmacokinetics of paclitaxel-containing liposomes in rats.

AAPS pharmSci·2004
See all related articles

Pharmacogenomics uses genetic insights to improve drug discovery, development, and patient therapy. This science impacts pharmaceutical development and clinical drug use for personalized medicine.

Area of Science:

  • Genomic Medicine
  • Translational Science

Background:

  • Pharmacogenomics integrates genetic principles into drug development and clinical practice.
  • The core aim is to achieve optimal, individualized drug therapy for each patient.

Purpose of the Study:

  • Analyze current trends in pharmacogenomics.
  • Evaluate the impact of pharmacogenomics on pharmaceutical drug development.
  • Assess the influence of pharmacogenomics on the clinical application of drugs.

Main Methods:

  • Literature review of current pharmacogenomic research and industry practices.
  • Analysis of scientific publications and industry reports.
  • Synthesis of findings on drug discovery, development, and clinical use.

Main Results:

Related Experiment Videos

  • Pharmacogenomics is a key driver in modern drug discovery and development pipelines.
  • The science enables more targeted and effective drug therapies.
  • Significant shifts are observed in pharmaceutical industry strategies and clinical prescribing.

Conclusions:

  • Pharmacogenomics is revolutionizing personalized medicine by tailoring treatments to individual genetic profiles.
  • The pharmaceutical industry is increasingly adopting pharmacogenomic approaches for efficient drug development.
  • Clinical adoption of pharmacogenomics promises enhanced therapeutic outcomes and reduced adverse drug reactions.